Latest content
ASCO 2026: Key market shifts and considerations
Every year, ASCO stands as a defining moment in oncology research, and the 2026 meeting was no different. Our team has distilled the conference’s most significant market shifts and strategic imperatives, cutting through the volume to focus on what truly matters. Below...
Where’s the “L” in CVRM?
The move towards a holistic approach is advancing at pace The increasing recognition of biological and clinical interconnection between cardiovascular, renal, and metabolic (CVRM) diseases is clear to see. A shift away from siloed, stepwise treatment approaches...
Designing Patient Research for Real Lives (vs. Ideal Scenarios)
Patients don’t behave the way they used to. They’re not just turning up for appointments and following instructions. They’re researching symptoms at 2 am, sense-checking decisions in niche patient forums, and watching other patients talk about their experiences on...